Osmozis SA reported earnings results for the full year ended August 31, 2021. For the full year, the company reported sales was EUR 9.59 million compared to EUR 8.01 million a year ago. Net income was EUR 0.990436 million compared to net loss of EUR 1.97 million a year ago. Basic earnings per share from continuing operations was EUR 0.46 compared to basic loss per share from continuing operations of EUR 0.92 a year ago. Diluted earnings per share from continuing operations was EUR 0.42.